The use of drugs (e.g., heparin, low-molecular-weight heparin, or warfarin) that inhibit or interrupt coagulation, inhibit or deactivate thrombin, prevent conversion of fibrinogen to fibrin, and inhibit blood clot formation. It is used to prevent or treat disorders, such as pulmonary embolism, that result from vascular thrombosis.